Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Kate, Mahon"'
Autor:
Heidi Fettke, Chao Dai, Edmond M. Kwan, Tiantian Zheng, Pan Du, Nicole Ng, Patricia Bukczynska, Maria Docanto, Louise Kostos, Siavash Foroughi, Stephen Brown, Lisa-Jane K. Graham, Kate Mahon, Lisa G. Horvath, Shidong Jia, Manish Kohli, Arun A. Azad
Publikováno v:
EBioMedicine, Vol 95, Iss , Pp 104738- (2023)
Summary: Background: Genomic alterations in DNA damage response (DDR) genes are common in metastatic castration-resistant prostate cancer (mCRPC). Understanding how these genomic events impact prognosis and/or treatment response is vital for optimisi
Externí odkaz:
https://doaj.org/article/868bde2315c940f2aff0e43052a1b905
Autor:
Phyllis Butow, Charbel Sandroussi, Kate Mahon, Wendy Brown, Michael Solomon, Lisa Horvath, Daniel Steffens, Kate White, Paul Sutton, Jane Young, Sharon Carey, David Yeo, Kilian Brown, Kheng-Seong Ng, Cherry Koh, Nabila Ansari, Alix Dumitrescu, Kate McBride, Glen Salkeld, Des Winter
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction Pelvic exenteration (PE) surgery represents the only potentially curative treatment option for patients with locally advanced or recurrent rectal cancer (LARRC). Given the potential morbidity, whether or not PE should be recommended for
Externí odkaz:
https://doaj.org/article/56901429aedd41cca2df853dfb80050a
Autor:
Blossom Mak, Hui-Ming Lin, Edmond M. Kwan, Heidi Fettke, Ben Tran, Ian D. Davis, Kate Mahon, Martin R. Stockler, Karen Briscoe, Gavin Marx, Alison Zhang, Megan Crumbaker, Winston Tan, Kevin Huynh, Thomas G. Meikle, Natalie A. Mellett, Andrew J. Hoy, Pan Du, Jianjun Yu, Shidong Jia, Anthony M. Joshua, David J. Waugh, Lisa M. Butler, Manish Kohli, Peter J. Meikle, Arun A. Azad, Lisa G. Horvath
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background Both changes in circulating lipids represented by a validated poor prognostic 3-lipid signature (3LS) and somatic tumour genetic aberrations are individually associated with worse clinical outcomes in men with metastatic castratio
Externí odkaz:
https://doaj.org/article/0c49ff062a1c4a14adec64ab46d60c0a
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Appendiceal cancer is rare and encompasses a diverse group of tumours ranging from low-grade appendiceal mucinous neoplasms to high-grade adenocarcinomas. Appendiceal cancers often spread to the peritoneal cavity causing extensive mucinous disseminat
Externí odkaz:
https://doaj.org/article/339cfaf4b4e6406384b520232daf470b
Publikováno v:
Journal of Clinical Oncology.
Autor:
Tahlia Scheinberg, Hui-Ming Lin, Michael Fitzpatrick, Arun A. Azad, Paul Bonnitcha, Amy Davies, Gillian Heller, Kevin Huynh, Blossom Mak, Kate Mahon, David Sullivan, Peter J. Meikle, Lisa G. Horvath
Publikováno v:
Prostate Cancer and Prostatic Diseases.
Background Using comprehensive plasma lipidomic profiling from men with metastatic castration-resistant prostate cancer (mCRPC), we have previously identified a poor-prognostic lipid profile associated with shorter overall survival (OS). In order to
Autor:
Kate Mahon
Publikováno v:
Critical reviews in oncogenesis. 27(1)
Effective biomarkers provide the potential to significantly improve treatment decisions and outcomes in prostate cancer patients. While the literature is inundated with prostate cancer biomarkers in the early phases of testing, very few reach the cli
Autor:
Blossom Mak, Hui-Ming Lin, Edmond M. Kwan, Heidi Fettke, Ben Tran, Ian D. Davis, Kate Mahon, Martin R. Stockler, Karen Briscoe, Gavin Marx, Alison Zhang, Megan Crumbaker, Winston Tan, Kevin Huynh, Thomas G. Meikle, Natalie A. Mellett, Andrew J. Hoy, Pan Du, Jianjun Yu, Shidong Jia, Anthony M. Joshua, David J. Waugh, Lisa M. Butler, Manish Kohli, Peter J. Meikle, Arun A. Azad, Lisa G. Horvath
Publikováno v:
BMC medicine. 20(1)
Background Both changes in circulating lipids represented by a validated poor prognostic 3-lipid signature (3LS) and somatic tumour genetic aberrations are individually associated with worse clinical outcomes in men with metastatic castration-resista
Autor:
Edmond M, Kwan, Heidi, Fettke, Megan, Crumbaker, Maria M, Docanto, Sarah Q, To, Patricia, Bukczynska, Andrew, Mant, Nicole, Ng, Siavash, Foroughi, Lisa-Jane K, Graham, Anne-Maree, Haynes, Sarah, Azer, Lisi Elizabeth, Lim, Eva, Segelov, Kate, Mahon, Ian D, Davis, Phillip, Parente, Carmel, Pezaro, Tilman, Todenhöfer, Niranjan, Sathianathen, Christine, Hauser, Lisa G, Horvath, Anthony M, Joshua, Arun A, Azad
Publikováno v:
Transl Androl Urol
BACKGROUND: As potent systemic therapies transition earlier in the prostate cancer disease course, molecular biomarkers are needed to guide optimal treatment selection for metastatic hormone-sensitive prostate cancer (mHSPC). The value of whole blood